Chief Medical Officer of Cytosorbents Corporation (NASDAQ:CTSO) Mortensen Eric R. exercised option of 5,000 shares of the company stock in a transaction on August 14, 2019 at an average price of $ 4.50.
The total value of the exercised option was approximately $ 22.50 thousand.
Following the transaction, the Chief Medical Officer now owns 148.93 thousand shares in the company.
The transaction was disclosed in a legal filing with the U.S. Securities and Exchange Commission, which is available through SEC Filing Link.
According to the previous trading day, closing price of CTSO was $ 4.77, representing a 22.85 % increase from the 52 week low of $ 3.68 and a 213.42 % decrease over the 52 week high of $ 14.95.